Your browser doesn't support javascript.
loading
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.
Oliveira, Giacomo; Stromhaug, Kari; Cieri, Nicoletta; Iorgulescu, J Bryan; Klaeger, Susan; Wolff, Jacquelyn O; Rachimi, Suzanna; Chea, Vipheaviny; Krause, Kate; Freeman, Samuel S; Zhang, Wandi; Li, Shuqiang; Braun, David A; Neuberg, Donna; Carr, Steven A; Livak, Kenneth J; Frederick, Dennie T; Fritsch, Edward F; Wind-Rotolo, Megan; Hacohen, Nir; Sade-Feldman, Moshe; Yoon, Charles H; Keskin, Derin B; Ott, Patrick A; Rodig, Scott J; Boland, Genevieve M; Wu, Catherine J.
Afiliação
  • Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. giacomo_oliveira@dfci.harvard.edu.
  • Stromhaug K; Harvard Medical School, Boston, MA, USA. giacomo_oliveira@dfci.harvard.edu.
  • Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Klaeger S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wolff JO; Harvard Medical School, Boston, MA, USA.
  • Rachimi S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Chea V; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Krause K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Freeman SS; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Zhang W; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Li S; Department of surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Braun DA; Harvard Medical School, Boston, MA, USA.
  • Neuberg D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Carr SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Livak KJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Frederick DT; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wind-Rotolo M; Harvard Medical School, Boston, MA, USA.
  • Hacohen N; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Sade-Feldman M; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • Yoon CH; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Keskin DB; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rodig SJ; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Boland GM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wu CJ; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
Nature ; 605(7910): 532-538, 2022 05.
Article em En | MEDLINE | ID: mdl-35508657
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T CD4-Positivos / Melanoma / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T CD4-Positivos / Melanoma / Antígenos de Neoplasias Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido